WILMINGTON, Mass. -- (BUSINESS WIRE) -- Kapa Biosystems, Inc., a leading supplier of reagents for the life science market, today announced several high-profile additions to its management team, along with the relocation of its corporate and international headquarters to larger facilities in Wilmington, Mass. and Cape Town, South Africa respectively. Combined, these new locations offer more than 25,000 square feet, which more than doubles the company’s previous facility investment. These new hires and larger facilities enable the company to scale enzyme production, quality control and manufacturing capacity across its four business franchises, increase headcount and expand R&D initiatives to better serve its growing number of customers around the world.
“Over the past eight years, Kapa Biosystems has transformed from a startup with a proprietary protein engineering technology platform to a global commercial organization with a best-in-class portfolio of products for genomics research and diagnostic applications,” said Christopher McGuinness, Co-Founder and Chief Operating Officer at Kapa Biosystems. “With these recent additions to our leadership team and the larger facilities, we now have the expertise and resources needed to deliver more enabling product solutions, develop more strategic business partnerships and drive more widespread customer adoption.”
Experienced Leadership Team Appointments
As part of its corporate growth strategy, Kapa Biosystems recently hired four industry veterans to lead key business functions. These new team members bring significant experience in operations, sales and marketing to support growing life science companies.
The company plans on filling the new office space by making additional hires for positions across a range of scientific, technical, marketing, and sales disciplines. For more information on available positions, please visit: http://www.kapabiosystems.com/company/careers.
About Kapa Biosystems
Kapa Biosystems is a life science reagents supplier that employs proprietary, directed evolution technologies to optimize enzymes for PCR, real-time PCR, next generation sequencing and molecular diagnostic applications. Kapa Biosystems offers a portfolio of best-in-class products containing novel enzymes that confer significant performance advantages when compared to traditional wild-type enzymes. The company is based in Wilmington, Massachusetts with a research, development and manufacturing facility in Cape Town, South Africa. For more information, please visit www.kapabiosystems.com.
KAPA is a trademark of Kapa Biosystems. All other brands may be trademarks of their respective holders.
Kapa Biosystems’ products are for Research Use Only; not for use in diagnostic procedures.